UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046231
Receipt number R000052761
Scientific Title Lateralized effects of transcranial magnetic stimulation on temporal lobe over autonomic functions
Date of disclosure of the study information 2021/11/30
Last modified on 2025/06/16 17:23:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Transcranial magnetic stimulation effects on heart rate variability

Acronym

Lateralized effects of transcranial magnetic stimulation on temporal lobe over autonomic functions

Scientific Title

Lateralized effects of transcranial magnetic stimulation on temporal lobe over autonomic functions

Scientific Title:Acronym

Transcranial magnetic stimulation effects on heart rate variability

Region

Japan


Condition

Condition

healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Low frequency repetitive transcranial magnetic stimulation over temporal lobe could affect heart rate variability since temporal lobe and autonomic center such as insula are close and functionally connected. However, those effects are not investigated for now. Threfore rTMS effects over tempora lobes are investigated regarding heart rate variability.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Hear rate or heart rate variability during or after rTMS compared with before rTMS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Left hemispheric stimulation

Interventions/Control_2

Right hemispheric stimulation

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults who can express informed consent by documents.

Key exclusion criteria

No history of neurological or psychiatric disorders

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Katsuya
Middle name
Last name Ogata

Organization

Interanational University of Health and Welfare

Division name

School of Pharmaceutical Sciences at Fukuoka

Zip code

831-8501

Address

Enokizu 137-1, Okawa, Fukuoka

TEL

0944-89-2000

Email

ogata_k@iuhw.ac.jp


Public contact

Name of contact person

1st name Katsuya
Middle name
Last name Ogata

Organization

International University of Health and Welfare

Division name

School of Pharmaceutical Sciences at Fukuoka

Zip code

831-8501

Address

Enokizu 137-1, Okawa, Fukuoka

TEL

0944-89-2000

Homepage URL


Email

ogata_k@iuhw.ac.jp


Sponsor or person

Institute

School of Pharmaceutical Sciences at Fukuoka, International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board in Kyushu, International University of Health and Welfare

Address

Enokizu 137-1, Okawa, Fukuoka

Tel

0944-89-2000

Email

q-rinri@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results

There was increase of heart rate during right temporal region.

Results date posted

2023 Year 06 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

none

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 09 Month 03 Day

Date of IRB

2019 Year 09 Month 03 Day

Anticipated trial start date

2019 Year 09 Month 04 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 11 Month 30 Day

Last modified on

2025 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052761